Upcoming Medical Conferences in BahamasSearch Criteria : Bahamas
Dec 06 - 09, 2018 | CME 16.00 | USD $1095 | Nassau, New Providence
Cardiology & Pulmonology for Primary Care is organized by Medical Education Resources (MER) and will be held from Dec 06 - 09, 2018 at Atlantis Bahamas, Nassau, New Providence, Bahamas. The target audience for this medical event is office-based primary care providers and other health professionals with updates in primary care medicine. This CME Conference has been approved for a maximum of 16 AMA PRA Category 1 Credits. Learning Objectives : Upon completion of this program, participants should be better able to: • Describe current diagnostic approaches to hypertension, congestive heart failure, arrhythmias, ACS and CAD • Implement treatment strategies reflective of current evidence based medicine for hypertension, congestive heart failure, arrhythmias, ACS and CAD • Identify the pathophysiology and diagnostic approach of asthma, COPD and common respiratory infections • Design treatment strategies reflective of current evidence based medicine for asthma, COPD and common respiratory infections • Discuss systemic consequences and counseling strategies, as well as available treatment options for sleep apnea, deep vein thrombosis and pulmonary embolism • Perform a range of pulmonary diagnostics and be better prepared to handle pulmonary nodules and lung cancer Additional details will be posted as soon as they are available.
Jan 02 - 08, 2019 | CME 28.50 | Paradise Island, New Providence
35th Annual Conference and 19th Annual Conference is organized by Center for Human Genetics, INC. and will be held from Jan 02 - 08, 2019 at Atlantis Paradise Island, Paradise Island, New Providence, Bahamas. 35th Annual Conference - January 2-6, 2019 19th Annual Conference - January 6-8, 2019 Accreditation: The 35th Annual Conference Cine-Med designates this live activity for a maximum of 19 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The 19th Annual Conference Cine-Med designates this live activity for a maximum of 14.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Joint Conference Cine-Med designates this live activity for a maximum of 28.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The major objectives in these two conferences are to enhance the continuing education of a range of specialties in medicine and allied professions, including obstetrics, gynecology, midwifery, neonatology, medicine, surgery, family medicine, emergency medicine, cardiology, radiology, human genetics, and ethics. The key reasons that have characterized the success of these conferences for the past 34 and 18 years, respectively, are the highly qualified and renowned medical faculty, and the insights and lessons concerning the role of law and lawyers, communicated by acknowledged “super lawyers.” Only through a thorough understanding of the complexities of medicine and law can physicians and litigators hope to deal effectively with the continuing challenges of medical and legal practice. The specific goals of these conferences are to: Teach healthcare professionals to better comprehend the machinations of negligence law, and to develop a more complete awareness of the need for anticipatory and safety practice. Teach legal professionals about the complex issues encountered in the practice of medicine, including the intricacies of decision-making, aiming to sharpen their understanding on behalf of their clients, both plaintiff and defense. Learning Objectives: At the conclusion of this conference, healthcare professionals will be able to articulate the role of law and lawyers in medical malpractice and discuss the complexities of the legal process. At the conclusion of this conference, legal professionals will be able to describe the best-evidence in medical malpractice as it pertains to obstetrics, gynecology, midwifery, neonatology, medicine, surgery, family medicine, emergency medicine, cardiology, radiology, and human genetics.
Feb 11 - 15, 2019 | CME 20.00 | USD $745 | Paradise Island, New Providence
38th Annual Series Emergency Medicine & Acute Care: A Critical Appraisal is organized by The Center for Medical Education, Inc and will be held from Feb 11 - 15, 2019 at Atlantis Bahamas, Paradise Island, New Providence, Bahamas. The target audience for this medical event is Physicians, PAs and NPs who practice in emergency departments and are seeking an evidence-based, literature-focused update in controversial areas of emergency care. This CME Conference has been approved for a maximum of 20 CME Credits. Course Description: A Focused, Evidence-Based Course Designed to Significantly Advance Your Practice of Emergency Medicine. Come Join Us for Our 38th Annual Series! Take a break to recharge with friends, family and colleagues in some truly world-class destinations while attending a course designed to challenge and inspire and which, because of its unique format and content, has had over 47,000 participants since inception. The Emergency Medicine & Acute Care course series has been presented over 400 times and has been held throughout the United States as well as in Canada, Mexico, Panama, Bermuda, the U.S. Virgin Islands, Costa Rica, Chile, London and Paris. Learning Objectives: After attending this course, participants will be able to: • Discuss key points from the literature regarding leading-edge Emergency Medicine topics • Discuss literature-based recommendations for practice improvement • Effectively translate the acquired strategies into improved diagnostics and subsequently implement a better treatment plan for their patients Additional details will be posted as soon as they are available.
6th Nucleic Acids Conference is organized by Fusion Conferences Ltd and will be held during Feb 13 - 16, 2019 at Melia Nassau Beach All Inclusive, Nassau, New Providence, Bahamas. Conference Description : The key role of nucleic acids is to encode and process genetic information at a molecular level. DNA is the genetic library of the cell, while RNA transports, translates and controls the expression of that information. DNA must be copied with unprecedented accuracy once every cell cycle. It is under constant endogenous and environmental onslaught, and a variety of repair pathways are necessary to maintain the integrity of the genetic blueprint. DNA is the only cellular molecule for which repair occurs to a significant extent. DNA undergoes recombination, a kind of molecular cut and re-join that creates diversity to facilitate evolution, as well as providing an important repair pathway. In eukaryotes something like 2m DNA is packaged into chromosomes so that it packs into the cell nucleus with a diameter of just 6 µm, while remaining accessible to the cellular machinery that reads out its genetic information. Understanding processes involving DNA and RNA at the molecular and chemical level is the central theme of this conference, with a marked structural and mechanistic perspective. The meeting will provide a platform for researchers to discover and discuss the latest advances in the field of nucleic acids, DNA and RNA, with exciting opportunities to share and receive feedback on unpublished data. Conference Topics : • DNA replication. • DNA repair. • DNA recombination. • RNA structure and function. • Translation and the ribosome. • Silencing. • CRISPR/Cas and genome editing. • Gene regulation and riboswitches. • RNA catalysis. Additional details will be posted as soon as they are available.
Feb 15 - 18, 2019 | Nassau, New Providence
3rd Fibroblast Growth Factors in Development and Repair Conference is organized by Fusion Conferences Ltd and will be held during Feb 15 - 18, 2019 at Melia Nassau Beach All Inclusive, Nassau, New Providence, Bahamas. Target Audience FGFs are key regulators of development, repair, disease, and metabolic homeostasis for many organs and therefore, FGF researchers come from various disciplines. These include structural biologists, biochemists, cell biologists, clinical researchers, clinicians, geneticists, pharmacologists and bioengineers. FGF meetings usually attract people from academia, but also from various pharmaceutical companies due to the important roles of FGFs and FGF receptors as drug targets. Learning Objectives We aim to bring together a diverse group of researchers with different expertise and skills in a single forum to discuss the latest results, to exchange ideas, to foster new and often interdisciplinary collaborations and to identify the major new direction of the field. Key Sessions will cover the following aspects: • FGF signalling in normal and impaired development • Role of FGFs in stem cell biology • Interaction of FGF signalling with other signalling pathways • Role of endogenous and efficacy of exogenous FGFs in tissue repair and regeneration • Role of altered FGF signalling in human diseases, ranging from rare developmental disorders to major diseases such as metabolic syndrome and cancer • Role of FGFs and FGFRs as therapeutic targets • FGFs as endocrine hormones. Additional details will be posted as soon as they are available.
Feb 17 - 20, 2019 | USD $1922 | Nassau, New Providence
Epithelial Mesenchymal Interactions in Lung Development and Fibrosis Conference is organized by Fusion Conferences Ltd and will be held from Feb 17 - 20, 2019 at Melia Nassau Beach All Inclusive, Nassau, New Providence, Bahamas. Course Description: Lung development is governed by epithelial-mesenchymal interactions. These pathways are recapitulated during injury and repair. This conference will focus on understanding key processes underlying lung development, injury and repair in the context of age, environment and species, with the hope of better understanding disease development and to discover novel therapeutic approaches. We will highlight critical issues on lung epithelial biology such as stem cells and regenerative medicine, while expanding sessions to encompass themes such as single cell analytical approaches, cell-cell communication, dissect the biological distinctions mesenchymal proliferation as a repair mechanism and fibrosis; present the impact of new tools in single-cell analysis on understanding lung development, repair, and disease; and characterize epithelial-mesenchymal interrelationships that maintain lung homeostasis and orchestrate repair and regeneration. The entire program has been designed to achieve a better understanding of the key clinical research issues and how they relate to basic mechanistic investigation. Key Sessions: • Fgf signaling in lung development and fibrosis. • Aging and lung fibrosis. • Lung stem/progenitor cells and their regulation in health and disease. • Organoid cultures to model lung development and disease. • Epithelial-mesenchymal interactions in lung development and fibrosis. Time: 2:00 pm to 12:00 pm. Speakers: Saverio Bellusci (University of Giessen), Zea Borok (Keck School of Medicine of USC), Wellington Cardoso (Columbia University), Gianni Carraro (Cedars-Sinai), Harold Chapman (University of California, San Francisco), Elie El Agha (Justus-Liebig-University Giessen), John Engelhardt (University of Iowa Carver College of Medicine), Finn Hawkins (Boston University), Brigid Hogan (Duke University), Alison Humbles (MedImmune LLC), Carla Kim (Harvard Medical School), Melanie Koenigshoff (University of Colorado Denver), Mark Krasnow (Stanford University), Maya Kumar (Stanford School of Medicine), Daniel Lafkas (Genentech), Susan Majka (Vanderbilt University), Parviz Minoo (Keck School of Medicine of USC), Edward Morrisey (University of Pennsylvania), Paul Noble (Cedars-Sinai), David Ornitz (Washington University), Anne-Karina Perl (Cincinnati Children's Hospital), Jayaraj Rajagopal (Harvard University), Emma Rawlins (University of Cambridge), Jason Rock (Boston University), Jason Spence (University of Michigan), Xin Sun (University of California, San Diego), Nan Tang (National Institute of Biological Sciences), Victor Thannickal (University of Alabama at Birmingham), David Warburton (Keck School of Medicine of USC), Rui Zhao (Novartis) Additional details will be posted as soon as they are available.
Feb 19 - 22, 2019 | Nassau, New Providence
3rd Small Molecule Activation Conference is organized by Fusion Conferences Ltd and will be held during Feb 19 - 22, 2019 at Melia Nassau Beach All Inclusive, Nassau, New Providence, Bahamas. Conference Description: Small molecules are constituents of the air we breathe (e.g. N2, O2, CO2) and take part in element cycles and various metabolic processes. Further representatives (e.g. H2, CO, CH4) are produced/converted in nature under anaerobic conditions or in industrial processes on large scales. Hence, small molecules such as those mentioned are readily accessible and comparatively inexpensive, so that it is highly desirable to include them into syntheses of value-added products or to use them as reservoirs of chemical energy (fuels). However, at the same time they are typically quite thermodynamically stable, so that their utilization requires an activation step. The topic of this conference will thus be concerned with various aspects of small molecule activation, with a focus on molecular insights. It provides a stimulating and interdisciplinary environment for both senior scientists and young researchers to discuss latest progress in the field. Prices: Academic from: USD 1822.0, Industry from: USD 1822.0, Student from: USD 1533.0 Time: 2:00 pm to 12:00 pm Speakers: Mu-Hyun Baik (KAIST), Marcetta Darensbourg (Texas AandM University), William Evans (University of California Irvine), Karsten Meyer (Friedrich Alexander University Erlangen-Nürnberg), Oliver Einsle (University of Freiburg), Alan Goldman (Rutgers University), Osamu Ishitani (Tokyo Institute of Technology), Daniel Stack (Stanford University), David Milstein (Weizmann Institute of Science) Additional details will be posted as soon as they are available.
Feb 21 - 24, 2019 | CME 16.00 | USD $1095 | Nassau, New Providence
Internal Medicine for Primary Care: Cardio/Neuro/Onc/Rheum is organized by Medical Education Resources (MER) and will be held during Feb 21 - 24, 2019 at Atlantis Paradise Island, Nassau, New Providence, Bahamas. The target audience for this medical event is office-based primary care providers and other health professionals with updates in primary care medicine. This CME Conference has been approved for a maximum of 16.00 AMA PRA Category 1 Credits. Learning Objectives are : Upon completion of this program, participants should be better able to: • Describe current diagnostic approaches to arrhythmias, hypertension, ACS and CAD • Implement treatment strategies reflective of current evidence-based medicine for arrhythmias, hypertension, ACS and CAD • Evaluate and treat fibromyalgia • Utilize current evidence to design treatment strategies for inflammatory arthritis and osteoarthritis • Perform a neurological exam as well as distinguish signs of weakness and other neurological disorders • Describe the differential diagnosis and treatment of movement disorders • Discuss the approach and subsequent therapeutic management of the cancer patient, as well as the cancer survivor Additional details will be posted as soon as they are available.
Feb 21 - 24, 2019 | USD $1922 | Nassau, New Providence
4th Drug Discovery Re-Invented Conference is organized by Fusion Conferences Ltd and will be held from Feb 21 - 24, 2019 at Melia Nassau Beach All Inclusive, Nassau, New Providence, Bahamas. Conference Description: The fourth Drug Discovery Re-Invented Meeting brings together experts in medicinal chemistry, structure-based drug design, computational chemistry, emerging drug targets, and novel technology platforms. The meeting is extremely interactive with enthusiastic question and answer sessions following each talk. This meeting remains unique with respect to the breadth of participants and focuses on new approaches to discovering drugs. With large pharma reducing investment in internal early-stage research, drug pipelines will increasingly be filled by alternative sources. These players include: government, academic labs, non-profits, biotech companies, and pharmaceutical "open innovation" models. Key Sessions: • New Approaches in Biotech, Academia, and Pharma. • New Screening Technologies and Drug Targets. • Structure, Modeling, and Fragment-based Design. • Government and Non-profit Sector in Drug Discovery and Development. • Importance of CROs in Supporting the Virtual Drug Discovery Model. • Emerging Pharmacological Targets. • Industry Exhibit. Time:14:00 to 12:00 Speakers: Vicky Steadman (Selcia Ltd), Jay Wrobel (FCCDC), Andrew Cole (Arbutus Bio), Vicki Feher (Schrodinger), Ted Price (Cercis Therapeutics), Christopher Savile (Intrexon), Bart DeCorte (Merachem), Matt Todd (Blumberg Institute) Additional details will be posted as soon as they are available.
Feb 23 - 26, 2019 | Nassau, New Providence
3rd Exploring DNA Repair Pathways as Targets for Cancer Therapy Conference is organized by Fusion Conferences Ltd and will be held during Feb 23 - 26, 2019 at Melia Nassau Beach All Inclusive, Nassau, New Providence, Bahamas. Conference Description : Defect in DNA damage repair and checkpoint control is the underlying mechanism for tumorigenesis, since it allows the accumulation of multiple genetic alternations, which are essential for the initiation of tumorigenesis. This has been clearly illustrated to be the cause of several human cancer-prone syndromes and also revealed by recent human genome studies. On the other hand, defective DNA repair and checkpoint activation also make cancer cells more vulnerable for particular DNA damaging agents or inhibitors that specifically disrupt some of these checkpoint pathways. With the increasing understanding of defects in DNA repair and checkpoint control in tumorigenesis, there are extensive interests in exploring these deficiencies, especially taking advantage of the synthetic lethality concept and targeting particular DNA repair and checkpoint pathways for cancer therapy. The purpose of this conference is to bring together basic, translational and clinical investigators and discuss the current and future directions, opportunities and obstacles in the development of these anti-cancer modalities and how to best apply these concepts in clinical practice. Key Sessions : • Highlight recent advances in the field of DNA damage repair. • Identify novel targets in DNA repair and checkpoint pathways. • Explore the concept of synthetic lethality for cancer treatment. • Assess the therapeutic potential of new anti-cancer modalities. • Learn mechanisms of therapeutic resistance and ways to improve cancer therapy. Additional details will be posted as soon as they are available.